PCSK9 Inhibitor [EPC] class drugs

3 results

  • praluent - alirocumab injection, solution

    (Alirocumab)
    Regeneron Pharmaceuticals, Inc.
    Praluent reduces LDL cholesterol in adults with hypercholesterolemia, HeFH, or HoFH (ages 8+), and lowers the risk of major cardiovascular events—heart attack, stroke, coronary death, or unstable angina—in high-risk adults.
    Medication Details
    Drug Interactions

  • repatha - evolocumab injection, solution

    (Evolocumab)
    Amgen Usa Inc.
    Repatha reduces the risk of major cardiovascular events (CV death, heart attack, stroke) in high-risk adults, and lowers LDL cholesterol in adults with hypercholesterolemia and patients aged 10+ with heterozygous or homozygous familial hypercholesterolemia, as an adjunct to diet and exercise.
    Medication Details
    Drug Interactions